Catalog Research
NST Research · Literature Intelligence

Research Radar

New research on the compounds in our catalog, labeled by what kind of evidence it is. Indexed from PubMed, ClinicalTrials.gov and Europe PMC, ranked by strength of evidence and recency, and linked to the original source.

75 items16 compounds7 human RCTs / meta-analyses20 animal / in-vitroupdated November 13, 2026refreshed 3× weeklyHow to read this
Join the Research Circle →
Read this first. The Research Radar summarizes third-party research for informational and research-use purposes only. It is not medical advice, and NST makes no claim that any compound is safe or effective for human or veterinary use. NST products are sold for research use only (RUO) and are not for human consumption. Evidence quality varies widely: many items are animal or cell studies, and preclinical findings often do not translate to humans. NST is not affiliated with, or endorsed by, any cited author, journal, registry or video creator. How we select and label items.
Evidence on file, by compoundHow much published research exists, and what kind. PubMed counts include everything indexed, not only what is listed below; each number links to the search behind it, so you can check it.
CompoundPubMed recordsHuman RCTsHuman clinical, all designsMeta-analyses & systematic reviewsReviewsAnimal-onlyOn the RadarResearch article
5-Amino-1MQAnimal and lab research only · thin literature 300000 none yet Article
AOD-9604Animal and lab research only · thin literature 2200093 3 review Article
BPC-157 + TB-500Human data limited to non-randomized reportsCounts cover BPC-157 and TB-500 by name (not the parent protein thymosin beta-4). 25402154112 3 review · 1 registered · 2 commentary Article
CJC-1295 + IpamorelinSome human randomized trials 753401224 none yet Article
EpitalonSome human randomized trialsCounts cover epitalon and epithalamin, the pineal extract it was modelled on. 19157022113 3 review · 3 lab Article
GHK-CuVery limited human randomized-trial data 1531501629 1 review · 2 registered · 2 lab Article
GlutathioneSubstantial human trial literatureCounts cover glutathione given as a supplement or drug. 4,046149250251242,400 2 review · 2 lab Article
HCGSubstantial human trial literatureCounts cover title mentions only; hCG is an approved drug with a very large literature. 10,1972761,339603901,790 1 RCT/MA · 2 human · 1 review · 1 lab · 1 commentary Article
IGF-1 LR3Human data limited to non-randomized reports 99010267 none yet Article
KPVAnimal and lab research only 1080001048 1 review · 4 lab Article
MOTS-cSome human randomized trials 2694815954 3 review · 1 registered · 1 lab Article
MT-2Very limited human randomized-trial data 252116114157 2 human Article
NAD+Substantial human trial literatureCounts cover NAD+ given as a supplement or infusion, incl. the precursors NMN and NR. 5,56273167267411,849 2 review · 1 registered · 3 lab Article
PT-141Substantial human trial literature 11614196587 1 RCT/MA · 2 review · 2 registered · 1 lab Article
RetatrutideSubstantial human trial literature 21811162413511 4 RCT/MA · 2 review Article
SelankVery limited human randomized-trial data 68230349 1 lab · 1 preprint Article
SemaxVery limited human randomized-trial data 21014011145 1 review · 1 lab · 1 commentary Article
SS-31Substantial human trial literature 4731927298170 1 human · 3 review · 1 registered · 1 lab Article
TesamorelinSubstantial human trial literature 10722273353 1 RCT/MA · 3 registered Article
Thymosin Alpha-1Substantial human trial literature 63140731286185 none yet
202629
Retatrutide
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial↗
Human RCT / meta-analysisRandomized controlled trial · Phase III

What this is: A randomized controlled trial in people, the strongest single-study design. One trial is not proof; check who was studied and what it was compared against in the source.

Bajaj HS et al.·Lancet·2026·DOI 10.1016/s0140-6736(26)00967-0·PMID 42250575Research article
BPC-157 + TB-500
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery↗
Registered trialTrial registration · Phase 1 · not yet recruiting · randomized · 30 participants planned

What this is: A trial registered on ClinicalTrials.gov: a record of a planned or running study. No results are posted. A registration is not evidence that anything works.

ClinicalTrials.gov Phase 1·2026·Registry NCT07803250Research article
GHK-Cu
Topical GHK-Cu Gel for Acute Skin Wound Healing↗
Registered trialTrial registration · Phase 2 · recruiting · randomized · 60 participants planned

What this is: A trial registered on ClinicalTrials.gov: a record of a planned or running study. No results are posted. A registration is not evidence that anything works.

ClinicalTrials.gov Phase 2·2026·Registry NCT07437586Research article
Semax
[Expert Council resolution: adjunctive pharmacotherapy for hyperkinetic disorders (attention deficit hyperactivity disorder) in children and adolescents]↗
Commentary / videoGuideline / expert consensusDiscusses Semax among other topics

What this is: A guideline or consensus statement from an expert group. It is expert opinion, not new data, and may reflect one country's practice.

Lapochkin OL et al.·Zh Nevrol Psikhiatr Im S S Korsakova·2026·DOI 10.17116/jnevro2026126092126·PMID 42910684Research article
202522
Retatrutide
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial↗
Human RCT / meta-analysisSubstudy of a randomized controlled trial · Phase II

What this is: A randomized controlled trial in people, the strongest single-study design. One trial is not proof; check who was studied and what it was compared against in the source.

Coskun T et al.·Lancet Diabetes Endocrinol·2025·DOI 10.1016/s2213-8587(25)00092-0·PMID 40609566Research article
BPC-157 + TB-500
BPC-157 + TB-500
202411
PT-141
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)↗
Registered trialTrial registration · Phase 3 · completed · randomized · 193 participants enrolled

What this is: A trial registered on ClinicalTrials.gov: a record of a planned or running study. No results are posted. A registration is not evidence that anything works.

ClinicalTrials.gov Phase 3·2024·Registry NCT04943068Research article
20236
Retatrutide
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA↗
Human RCT / meta-analysisRandomized controlled trial · Phase II

What this is: A randomized controlled trial in people, the strongest single-study design. One trial is not proof; check who was studied and what it was compared against in the source.

Rosenstock J et al.·Lancet·2023·DOI 10.1016/s0140-6736(23)01053-x·PMID 37385280Research article
20227
No items match those filters yet. Clear a filter to see more.

How to read the Radar

Every item carries an evidence label. Labels come from the publication types and study-subject tags that PubMed and Europe PMC assign, and from the ClinicalTrials.gov record for registered trials. Where a record is too new to be tagged yet, we label it from its title.

Evidence labels

Human RCT / meta-analysisRandomized controlled trials (RCTs) in people, or meta-analyses that pool earlier studies. The strongest designs, still not proof on their own.
Human study, non-randomizedStudies in people without randomization: open-label, observational, post-hoc analyses, case reports.
ReviewReviews and systematic reviews that summarize earlier work. No new data.
Registered trialA ClinicalTrials.gov record of a planned or running trial. A registration is not a result.
Animal / in-vitroStudies in animals, cells or other lab models. Findings often do not carry over to humans.
PreprintShared before peer review. Provisional.
Commentary / videoEditorials, letters, and third-party videos. Expert opinion, not new data.
Community / anecdoteForum posts, personal reports and social media. Defined here for completeness; the Radar never lists them.

How items are chosen

Abbreviations

RCT randomized controlled trial · DOI Digital Object Identifier, a permanent link to a publication · PMID PubMed identifier · RUO research use only.

Copyright and corrections

Titles and bibliographic details are shown only to identify each source; all rights remain with the publishers, authors and creators. We link to the original and never host articles, abstracts, figures, PDFs or video thumbnails. Rights-holders and authors can request a correction or removal at support@nstresearch.com.

The Research Circle

Your compounds, the moment the literature moves.

Join free. Pick the compounds you research and we will flag significant new studies on them, a registered trial, an approval, first-in-human data, the moment they are indexed. Personalized, neutral citations, no marketing.

Follow compoundsall compounds
FreePersonalized alerts on the compounds you follow, your own filtered radar, neutral citations. No cost, no marketing, unsubscribe anytime.
Premium soonEverything in Free, plus the full searchable archive, a weekly digest, CSV export, and earliest access to new studies.
Not carried yet? Tell us which research compounds to source next.
Research-literature updates only. Neutral citations, no marketing. Unsubscribe anytime.